Epidemiological profile and distribution of hansen’s disease" cases in the state of Amazonas
DOI:
https://doi.org/10.21527/2176-7114.2025.50.15442Keywords:
Hanseníase, Monitoramento Epidemiológico, Perfil de Saúde, Notificação de Doenças, Sistema de Informação em SaúdeAbstract
Objective: To describe the epidemiological profile and distribution of hansen’s disease cases in the state of Amazonas between 2018 and 2022. Method: This is a descriptive study based on secondary data with a quantitative approach, conducted in the 62 municipalities of the state of Amazonas. Data were obtained from reported cases in the Notifiable Diseases Information System (SINAN) during the period from 2018 to 2022. Results: Sociodemographic data reveal a higher number of cases among adult males and individuals of mixed race (pardo). Hansen’s disease also more frequently affects individuals with low educational attainment. Regarding clinical characteristics, 73.9% of cases were classified as multibacillary, with the dimorphic form being predominant and physical disability commonly classified as "grade zero." There was a statistically significant association between the operational classification and the number of lesions, clinical form, and therapeutic regimen. The Southern Mesoregion recorded the highest rates of new cases, with a significant shift in this pattern only in 2022. A reduction in hansen’s disease rates was observed across all mesoregions in 2020 and 2021, reflecting the impact of the COVID-19 pandemic. Conclusion: Hansen’s disease remains a prevalent disease among vulnerable populations in the state of Amazonas, with high incidence rates in all mesoregions. Active surveillance of hansen’s disease in Amazonas is essential, focusing on early detection and reduction of transmission sources. Continuous permanent education initiatives are necessary to train healthcare professionals in the proper identification and management of hansen’s disease cases.
References
1 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia prático sobre a hanseníase. Brasília: Ministério da Saúde; 2017.
2 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico - Hanseníase 2023. Número Especial. Brasília: Ministério da Saúde; 2023.
3 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Protocolo Clínico e Diretrizes Terapêuticas da Hanseníase. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Brasília: Ministério da Saúde; 2022.
4 Ferreira LM, et al. Hanseníase na Amazônia central: um olhar epidemiológico. Rev Med, São Paulo. 2023;102(2):e-194245. DOI: https://doi.org/10.11606/issn.1679-9836.v102i2e-194245
5 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviços. Guia de Vigilância em Saúde: volume único. 3. ed. Brasília: Ministério da Saúde; 2019.
6 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Estratégia Nacional para Enfrentamento da Hanseníase 2019-2022. Brasília: Ministério da Saúde; 2019.
7 Brasil. Ministério da Saúde. Informações de saúde: Tabnet. Demográficas e socioeconômicas 2018 a 2021 [Internet]. 2021 [acesso 15 jul. 2023]. Disponível em: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?ibge/cnv/popsvsbr.def
8 Instituto Brasileiro de Geografia e Estatística (IBGE). Censo Brasileiro de 2022. Rio de Janeiro: IBGE; 2022.
9 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Diretrizes para vigilância, atenção e eliminação da Hanseníase como problema de saúde pública: manual técnico-operacional. Brasília: Ministério da Saúde; 2016.
10 Oliveira MB, Diniz LM. Leprosy among children under 15 years of age: literature review. An Bras Dermatol. 2016;91:196-203. DOI: https://doi.org/10.11606/issn.1679-9836.v102i2e-194245
11 Santos MB, Santos MLR, Monteiro LD, Heukelbach J, Nobre ML. Clinical and epidemiological indicators and spatial analysis of leprosy cases in patients under 15 years old in an endemic area of Northeast Brazil: an ecological and time series study. BMJ Open. 2019;9(7):e023420. DOI: https://doi.org/10.1136/bmjopen-2018-023420
12 Oliveira JSS, Souza CD, Silva JCF, Goulart IMB, Goulart LR, Santos M. Leprosy in elderly people and the profile of a retrospective cohort in an endemic region of the Brazilian Amazon. PLoS Negl Trop Dis. 2019;13(9):e0007709. DOI: https://doi.org/10.1371/journal.pntd.0007709
13 Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: A systematic review. PLoS Negl Trop Dis. 2021;15(8):e0009651. DOI: https://doi.org/10.1371/journal.pntd.0009651
14 Palácios VR, Mendes LL, Dias J, Moraes TM, Ignotti E, Paula S. Leprosy and pregnancy: detection coefficient and proposal for a new index. Rev Soc Bras Med Trop. 2014;47:798-800. DOI: https://doi.org/10.1590/0037-8682-0019-2013
15 Santos KCB, Freitas LAR, Barreto JG, Goulart IM, Goulart LR. Estratégias de controle e vigilância de contatos de hanseníase: revisão integrativa. Saúde em Debate. 2019;43:576-591. DOI: https://doi.org/10.1590/0103-1104201912122
16 Nery JS, Pescarini JM, Mendes JM, Ichihara MY, de Araújo GS, Santana SR, et al. Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study. The Lancet Global Health. 2019;7(9):e1226-e1236. DOI: http://dx.doi.org/10.1016/ S2214-109X(19)30260-8
17 Ramos AC, Yamamura M, Arroyo LH, Popolin MP, Neto FC, Palha PF, et al. Spatial clustering and local risk of leprosy in São Paulo, Brazil. PLoS Negl Trop Dis. 2017;11(2):e0005381. DOI: https://doi.org/10.1371/journal.pntd.0005381
18 Lopes FC, Rodrigues RN, Castro CGJ, Andrade RV, Grilo LS, Costa DA, et al. Hanseníase no contexto da Estratégia Saúde da Família em cenário endêmico do Maranhão: prevalência e fatores associados. Ciênc Saúde Coletiva. 2021;26(5):1805-1816. DOI: https://doi.org/10.1590/1413-81232021265.04032021.
19 Sales BN, Ribeiro Neto AG, Silva PRP, Ferreira Júnior AM, Pinto IC. Caracterização epidemiológica da hanseníase nas regiões Norte e Nordeste do Brasil. Res Soc Dev. 2020;9(8):e894986313. DOI: http://dx.doi.org/10.33448/rsd-v9i8.6313
20 Cáceres-Durán MA. Comportamiento epidemiológico de la lepra en varios países de América Latina, 2011-2020. Rev Panam Salud Publica. 2023;46:e14. DOI: https://doi.org/10.26633/RPSP.2022.14
21 Pescarini JM, Strina A, Nery JS, Skalinski LM, Andrade KVF, Penna MLF, et al. Epidemiological characteristics and temporal trends of new leprosy cases in Brazil: 2006 to 2017. Rev Saude Publica. 2021;37(7):e0013002. DOI: https://doi.org/10.1590/0102-311X00130020
22 Silva JSR, Palmeira IP, Sá AMM, Nogueira LMV, Ferreira AMR. Variáveis clínicas associadas ao grau de incapacidade física na hanseníase. Rev Cuid. 2019;10(1):e618. DOI: https://doi.org/10.15649/cuidarte.v10i1.618
23 Serra MAAO, Furtado JP, Gonçalves FG, Santos FG, Peixoto LMB, Alencar CH. Factors associated with multibacillary leprosy in a priority region for disease control in northeastern Brazil: a retrospective observational study. J Trop Med. 2019;2019:5738924. DOI: https://doi.org/10.1155/2019/5738924
24 Pêgo AF, Eleutério D, Procópio JPM, Condé VAS, Gonçalves E. Hanseníase: correlação entre o número de lesões hansênicas, nervos afetados e o diagnóstico precoce no estado de Minas Gerais. Rev Eletr Acervo Saude. 2020;12(9):e2188. DOI: https://doi.org/10.25248/reas.e2188.2020
25 Espíndola MF, Santos FL, Silva RC, Oliveira VS, Silva JF, Reis RM, et al. Perfil epidemiológico da hanseníase no período de 2015 a 2018 no município de Goianésia (GO) Perfil epidemiológico da hanseníase em Goianésia, Goiás. Braz J Health Rev. 2020;3(2):2600-2611. DOI: https://doi.org/10.34119/bjhrv3n2-107
26 Cunha C, Vianna L, Marrero L, Cardoso M, Souza I, da Costa AM, et al. A historical overview of leprosy epidemiology and control activities in Amazonas, Brazil. Rev Soc Bras Med Trop. 2015;48:55-62. DOI: https://doi.org/10.1590/0037-8682-0103-2013
27 Health Health Organization (WHO). Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission. Wkly Epidemiol Rec. 2022;97:429-450.
28 Paz WS, Santos FQ, Nogueira LS, Souza BD, Silva RC, Duarte NC, et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study. Lancet Reg Health Am. 2022;9:100181. DOI: https://doi.org/10.1016/j.lana.2021.100181
29 Deps P, Collin SM, de Andrade VLG. Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to Covid-19 pandemic. J Eur Acad Dermatol Venereol. 2022;36(5):e339-e340. DOI: https://doi.org/10.1111/jdv.18307
30 Schmitz V, Santos JB. COVID-19, leprosy, and neutrophils. PLoS Negl Trop Dis. 2021;15(1):e0009019. DOI: https://doi.org/10.1371/journal.pntd.0009019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
